Thrombophilia Due to Acquired Antithrombin III Deficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Thrombophilia Due to Acquired Antithrombin III Deficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 4

NCT01547728

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

The objective of this study is to prospectively evaluate the response of recombinant antithrombin (rAT) (ATRYN) in patients who are heparin resistant and are sc…

United States42 participantsStarted 2012-02

Treatment: Recombinant antithrombin (rhAT)